Today: 20 June 2026
20 June 2026
2 mins read

Rocket Lab trades after rough holiday week ahead of Nasdaq-100 debut

NEW YORK, June 20, 2026, 13:02 (EDT)

  • Rocket Lab ended Thursday’s session at $107.24, off 0.69% for the day. Shares then fell to $106.20 after the bell. Nasdaq was closed Friday for Juneteenth.
  • The stock ended up about 4.7% from last Friday’s close, getting a boost Monday after an analyst upgrade and some index inclusion trades.
  • Rocket Lab will be added to the Nasdaq-100 on Monday before the open, putting the launch and space-systems firm into a key index used by over 200 investment products.

Rocket Lab is set to join the Nasdaq-100 on Monday. Shares ended the holiday-shortened week higher, despite tumbling on Thursday and pressure across new space stocks. Rocket Lab’s last close was $107.24. Some investors are asking how much of the expected index buying is already reflected in the stock.

Timing is key here. Rocket Lab is set to join the Nasdaq-100, which tracks bigger non-financial names on Nasdaq, ahead of the open on June 22. That move could push index funds—those that follow the benchmark instead of picking stocks—to hold the shares after the reshuffle.

Nasdaq said it will add Rocket Lab, along with Astera Labs, CoreWeave, Nebius and Teradyne. Charter Communications, Cognizant, Insmed, Verisk and Zscaler are out. Rocket Lab gets more market attention now, but joining the Nasdaq-100 comes with higher pressure. The index tends to draw new money, but it also can turn quickly if growth stocks slip.

Rocket Lab called it “a landmark moment.” Founder and CEO Sir Peter Beck said the inclusion showed the company’s shift “from a small company with big ambitions to a global space leader.” Rocket Lab said it has done more than 80 launches and put up over 250 satellites. It is also working on its medium-class Neutron rocket for constellation missions. GlobeNewswire

Rocket Lab’s shares swung sharply last week. The stock dropped 10.8% on Friday, then regained 6.7% on Monday. It lost 4.2% Tuesday, rebounded 3.2% Wednesday, and eased 0.7% Thursday. Trading was heavy Thursday, with about 70.3 million shares changing hands—more than double the daily volume of the previous three sessions. Traders appeared to be shifting positions ahead of the long weekend.

Wall Street had a hand in the shift. KeyBanc’s Michael Leshock bumped Rocket Lab up to Overweight, which signals the stock could outperform, and said the SpaceX-connected drop was “unwarranted,” MarketWatch reported. Firefly Aerospace also got an upgrade. Both moves came as analysts looked again at space stocks after SpaceX’s Nasdaq debut. MarketWatch

SpaceX is still dragging on the trade. Reuters said Thursday that SpaceX shares dropped over 6% as the post-IPO rush faded. Rocket Lab and Planet Labs also fell. Kat Liu, an analyst at IPOX Schuster, said “some degree of profit-taking is not surprising” after the offering’s size and quick start. Reuters

Insider filings landed late this week. According to a Form 4 with the Securities and Exchange Commission, Rocket Lab senior vice president and general counsel Arjun Kampani got rid of 88,000 shares at $107.98 each on June 18, moving them into an exchange fund, which can help diversify big stock positions. After the move, the filing says Kampani held 264,705 shares directly.

Rocket Lab’s latest numbers backed up its bullish case. The company said first-quarter revenue topped $200 million, and backlog ended the quarter at $2.2 billion—its total contracted work not yet booked as revenue. Rocket Lab also reported access to over $2 billion in liquidity, or available funding.

But there’s clear risk. A stock can win an index bid and still drop if traders think the good news is priced in. Rocket Lab is still in the high-expectation space trade. Delays with Neutron, softer launch demand, contract timing, insider selling headlines, or another SpaceX pullback could swing sentiment quickly. The new week kicks off with forced buying as the big story, but then execution needs to pick up the slack.

Leokadia Głogulska is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, space technology and global market developments. She graduated from Wrocław University of Economics and Business and previously worked in financial analysis before moving into business journalism. Her reporting focuses on helping readers understand the market trends, companies and technologies shaping the global economy.

Stock Market Today

  • Parabilis Medicines Director Buys $474,000 Shares Post-IPO, Signaling Confidence in PBLS Stock
    June 20, 2026, 1:37 PM EDT. Parabilis Medicines (NASDAQ:PBLS) director Alan Sebulsky purchased 17,500 shares for approximately $474,000 shortly after the company's IPO. The purchase, made through his investment vehicle Apothecary Capital LLC, raised his indirect holdings to 30,000 shares. The transaction price of $27.06 per share exceeded the June 15 closing price by about 8.2%, indicating strong confidence. Parabilis focuses on developing cell-penetrating miniproteins targeting cancer cells and has a $3.29 billion market cap. Sebulsky, noted for board roles at Jazz Pharmaceuticals and Arrow International, increasing his stake could be seen as a bullish indicator for investors assessing PBLS.

Latest articles

Rocket Lab trades after rough holiday week ahead of Nasdaq-100 debut

20 June 2026
Rocket Lab will join the Nasdaq-100 before Monday’s open, drawing index fund demand after a volatile week that saw shares close at $107.24 Thursday, up 4.7% from last Friday on analyst upgrades and index positioning, with trading volume surging ahead of the change and insiders diversifying holdings, but risks remain if index buying is already priced in.
MRVL stock gains as AI-networking names hit S&P 500 milestone

Marvell joins S&P 500 a week after KeyBanc upgrade and optics milestone

20 June 2026
Marvell surged 7.27% to $310.58 ahead of its June 24 S&P 500 debut, fueled by a KeyBanc price target hike to $385 and news it shipped over five million photonic ICs for AI data centers, as investors weigh index-driven inflows against risks of unsustainable AI infrastructure spending.
MRVL stock gains as AI-networking names hit S&P 500 milestone
Previous Story

Marvell joins S&P 500 a week after KeyBanc upgrade and optics milestone

Go toTop